Plewman Patrick's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Aug 21, 2025
- Accession no.
- 0001022079-25-000198
- Filed
- Aug 21, 2025
- Trade date
- Aug 19, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $829.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Plewman PatrickCIK 0001497368 | Officer (SVP for Diagnostic Services) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2025 | Common Stock | MOption exerciseAcquired | +4,532 | $112.17 | +$508,354.44 | 21,776 | Direct | |
| Aug 19, 2025 | Common Stock | SSaleDisposed | −4,532 | $183.00 | −$829,356 | 17,244 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2025 | Common Stock | MOption exerciseDisposed | −4,532 | $112.17 | −$508,354.44 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.